Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Patches Prior to Percutaneous Nerve Evaluation
NCT05783219Phase 2Completed
- Sponsor
- University of Louisville
- Start
- May 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lidocaine 10% oropharyngeal spray in procedural pain (2 arms), sponsored by University of Louisville. Primary endpoint: Visual Analog Scale Pain Score. Started May 2023; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT05783219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05783219.